Citigroup Inc 908 Devices Inc. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in 908 Devices Inc. stock. As of the latest transaction made, Citigroup Inc holds 2,260 shares of MASS stock, worth $13,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,260
Previous 10,904
79.27%
Holding current value
$13,311
Previous $77,000
75.32%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MASS
# of Institutions
110Shares Held
24.4MCall Options Held
39KPut Options Held
11.9K-
Awm Investment Company, Inc. New York, NY5.2MShares$30.6 Million5.32% of portfolio
-
State Street Corp Boston, MA2.29MShares$13.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.95MShares$11.5 Million0.12% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$9.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$8.37 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $186M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...